Literature DB >> 2170854

Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance.

M J Kelly1, M D Loose, O K Ronnekleiv.   

Abstract

Intracellular recordings were made from hypothalamic arcuate (ARC) neurons with biocytin-filled electrodes under current- and voltage-clamp in slices prepared from ovariectomized guinea pigs which were pretreated with estradiol. Forty-three neurons were identified after linking the intracellular biocytin with streptavidin-FITC and subsequently were examined for beta-endorphin immunoreactivity. Ten of these neurons were immunoreactive for beta-endorphin. beta-Endorphin neurons displayed the following passive membrane properties: RMP:-56 +/- 2 mV; Rin: 439 +/- 66 M omega; tau: 17.5 +/- 2.4 ms; and often fired spontaneously (5.9 +/- 2.2 Hz). These membrane characteristics were not different from identified neurons in the ARC that were not immunoreactive for beta-endorphin. beta-Endorphin neurons exhibited instantaneous inward rectification and time-dependent rectification. The mu-opioid agonist Tyr-D-Ala-Gly-MePhe-Gly-ol (DAGO) decreased spontaneous firing, induced membrane hyperpolarization (12 +/- 2 mV; range 6-22 mV) and decreased the Rin (38 +/- 4%) of the beta-endorphin neurons. These effects of DAGO were blocked by the opioid antagonist naloxone (1 microM) and were not blocked by 1 microM TTX. DAGO-responsive cells were unaffected by either kappa- or delta-receptor opioid agonists. These results indicate that mu-receptors may be autoreceptors on ARC beta-endorphin neurons and that activation of opioid mu-receptors hyperpolarizes beta-endorphin neurons via an increase in K+ conductance. Therefore, opioid peptides may modulate opioid tone through an 'ultra-short loop' feedback control mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170854     DOI: 10.1159/000125597

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  23 in total

Review 1.  Electrophysiological analysis of circuits controlling energy homeostasis.

Authors:  Masoud Ghamari-Langroudi
Journal:  Mol Neurobiol       Date:  2012-02-14       Impact factor: 5.590

2.  β-Endorphin antagonizes the effects of α-MSH on food intake and body weight.

Authors:  Roxanne Dutia; Kana Meece; Shveta Dighe; Andrea J Kim; Sharon L Wardlaw
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 3.  The hormonal signature of energy deficit: Increasing the value of food reward.

Authors:  Sarah H Lockie; Zane B Andrews
Journal:  Mol Metab       Date:  2013-08-19       Impact factor: 7.422

4.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Inmaculada Cubero; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

Review 5.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 6.  ACS chemical neuroscience molecule spotlight on contrave.

Authors:  Susan L Mercer
Journal:  ACS Chem Neurosci       Date:  2011-09-21       Impact factor: 4.418

7.  Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons.

Authors:  Reagan L Pennock; Shane T Hentges
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

8.  Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.

Authors:  Philip D Fox; Shane T Hentges
Journal:  J Neurosci       Date:  2017-08-07       Impact factor: 6.167

9.  Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression.

Authors:  Michelle Lee; Andrea Kim; Irene M Conwell; Victor Hruby; Alexander Mayorov; Minying Cai; Sharon L Wardlaw
Journal:  Peptides       Date:  2007-11-21       Impact factor: 3.750

10.  Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.

Authors:  Yan Zhou; Francesco Leri; Ann Ho; Mary Jeanne Kreek
Journal:  Neurochem Res       Date:  2013-06-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.